Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
This report aims to provide a comprehensive presentation of the global market for Personalized Medicines In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines In Oncology. This report contains market size and forecasts of Personalized Medicines In Oncology in global, including the following market information:
- Global Personalized Medicines In Oncology Market Revenue, 2018–2023, 2024–2030, ($ millions)
- Global top five companies in 2023 (%)
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7760912/global-personalized-medicines-in-oncology-forecast-2024-2030-87
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Molecular Oncopathology Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Personalized Medicines In Oncology include Biotheranostics, Illumina, DNA Link, Genomic Health, Inc.(Exact Sciences), Cypher Genomics(Human Longevity, Inc.), Life Technologies Corporation(Thermo Fisher Scientific), Fulgent Genetics, Caris Life Sciences and Ariana Pharma, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Personalized Medicines In Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Personalized Medicines In Oncology Market, by Type, 2018–2023, 2024–2030 ($ millions)
Global Personalized Medicines In Oncology Market Segment Percentages, by Type, 2023 (%)
- Molecular Oncopathology
- Genome Diagnostics
- Radiation Therapy
- Oncology Testing
- Chemotherapy
- Others
Global Personalized Medicines In Oncology Market, by Application, 2018–2023, 2024–2030 ($ millions)
Global Personalized Medicines In Oncology Market Segment Percentages, by Application, 2023 (%)
- Research Centers
- Governmental Institutions
- Hospitals
- Clinical Centers
- Others
Global Personalized Medicines In Oncology Market, By Region and Country, 2018–2023, 2024–2030 ($ Millions)
Global Personalized Medicines In Oncology Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Personalized Medicines In Oncology revenues in global market, 2018–2023 (estimated), ($ millions)
- Key companies Personalized Medicines In Oncology revenues share in global market, 2023 (%)
key players include:
- Biotheranostics
- Illumina
- DNA Link
- Genomic Health, Inc.(Exact Sciences)
- Cypher Genomics(Human Longevity, Inc.)
- Life Technologies Corporation(Thermo Fisher Scientific)
- Fulgent Genetics
- Caris Life Sciences
- Ariana Pharma
- Abbott Laboratories
- deCODE genetics
- Exagen Inc
Chapter 1: Introduces the definition of Personalized Medicines In Oncology, market overview.
Chapter 2: Global Personalized Medicines In Oncology market size in revenue.
Chapter 3: Detailed analysis of Personalized Medicines In Oncology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Personalized Medicines In Oncology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-personalized-medicines-in-oncology-forecast-2024-2030-87-7760912
Table of content
1 Introduction to Research & Analysis Reports
1.1 Personalized Medicines In Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Personalized Medicines In Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Personalized Medicines In Oncology Overall Market Size
2.1 Global Personalized Medicines In Oncology Market Size: 2022 VS 2029
2.2 Global Personalized Medicines In Oncology Market Size, Prospects & Forecasts: 2018–2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Personalized Medicines In Oncology Players in Global Market
3.2 Top Global Personalized Medicines In Oncology Companies Ranked by Revenue
3.3 Global Personalized Medicines In Oncology Revenue by Companies
3.4 Top 3 and Top 5 Personalized Medicines In Oncology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Personalized Medicines In Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Personalized Medicines In Oncology Players in Global Market
3.6.1 List of Global Tier 1 Personalized Medicines In Oncolog
Customize/Section/Part Purchase @ https://www.statsmarketresearch.com/chapters-purchase/7760912/global-personalized-medicines-in-oncology-forecast-2024-2030-87
CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781–7170 / +91 8087042414
Similar Reports:
Global Personalized Medicines In Oncology Market Insights, Forecast to 2028
Personalized Medicines In Oncology Market, Global Outlook and Forecast 2022–2028
Global and China Personalized Medicines In Oncology Market Size, Status and Forecast 2021–2027
